logo
episode-header-image
Apr 2021
24m 28s

The Johnson & Johnson Vaccine Pause Expl...

The New York Times
About this episode
Today, science writer Carl Zimmer explains the decision-making process, how long the suspension might last and the impact it could have not only in the U.S. but around the world. Guest: Carl Zimmer, a science writer and author of the “Matter” column for The New York Times. 
Up next
Yesterday
A Disastrous Day in Court for Trump
<p>A federal judge on Monday tossed out separate criminal charges against the former F.B.I. director James B. Comey and New York’s attorney general, Letitia James.</p><p>The manner in which the judge dismissed the Comey indictment could now lead to a legal fight over whether the ... Show More
22m 47s
Nov 24
The Autism Diagnosis Problem
<p>Once primarily limited to severely disabled people, autism began to be viewed as a spectrum that included children and adults far less impaired. Along the way, the disorder also became an identity, embraced by college graduates and even by some of the world’s most successful p ... Show More
32m 40s
Nov 23
Sunday Special: Wicked, Good?
<p>“Wicked” was one of the biggest movies of 2024. It was culturally ubiquitous, a box office smash and an Oscar nominee for Best Picture. Now, a year later, “Wicked: For Good” arrives in theaters to finish the tale of the complicated friendship between Glinda the Good Witch and ... Show More
51m 44s
Recommended Episodes
Apr 2021
Halted: Johnson & Johnson & the Vaccination Timeline
After 6 people in nearly 7 million Johnson & Johnson vaccine recipients developed a rare type of blood clot, the FDA and CDC have recommended a pause on administering that vaccine in the United States. CNBC’s Meg Tirrell digests the news and what it means for the rest of the J&J ... Show More
27m 20s
Apr 2021
The J & J Pause, Explained — And What It Means For The U.S. Vaccination Effort
The Centers for Disease Control and Prevention and the Food and Drug Administration announced a recommended pause in use of Johnson & Johnson's single-use COVID-19 vaccine, while the agencies investigate reports of a rare but serious blood clot in six people. The pause comes at a ... Show More
12m 41s
Apr 2021
J&J It Again, Sam
<p>The CDC and the FDA have lifted their recommended pause on the Johnson and Johnson COVID vaccine, and added a warning label about the very, very rare reported cases of blood clots. But overall vaccination rates in the US are slowing down, indicating that while supply is increa ... Show More
17m 53s
Feb 2021
FDA: Johnson & Johnson vaccine is safe and effective
The U.S. Food and Drug administration found the Johnson & Johnson coronavirus vaccine is safe and effective and meets the emergency use authorization requirements. If authorized, it’ll be the third shot option in the United States. Dr. Leana Wen is the former Baltimore Health Com ... Show More
46m 23s
Mar 2021
Europe’s vaccine disaster
Zack, Jenn, and Alex discuss the raft of problems stymying Europe’s vaccine rollout, which has been slower and messier than expected, given some of the earlier successes the continent had controlling infection rates. They talk about why some countries decided to pause administeri ... Show More
55m 59s
Apr 2021
The U.S. Vaccination Rate Continues To Slow
Short Wave's Emily Kwong talks with NPR health correspondent Allison Aubrey about some of the latest coronavirus news, including the return of the Johnson & Johnson vaccine in the U.S. and vaccine outreach in harder to reach communities. Have questions about the latest coronaviru ... Show More
11m 15s
Feb 2021
Third Vaccine On The Way, Fauci Hails 'Spectacular Results'
A third COVID-19 vaccine could receive emergency use authorization from the Food and Drug Administration this month. The vaccine made by Johnson & Johnson is 66% effective in preventing moderate to severe disease, according to a global study. Combined with the two vaccines curren ... Show More
12m 29s
Feb 2021
FDA recommends Johnson & Johnson Covid-19 vaccine
The FDA vaccine advisers recommended authorization of Johnson & Johnson’s coronavirus vaccine. In the U.S., the single-shot showed an overall efficacy of 72% in preventing moderate to severe disease and 85% effective in preventing severe disease. CNN’s Chief Medical Correspondent ... Show More
46m 10s
Apr 2021
Earth Day Stupidity | 4/22/21
Joe Biden has a history of racist comments. Amazon is testing new technology that uses the palm of your hand to identify shoppers. China has a new vaccine that has not been working particularly well, especially in Chile. The Pfizer vaccine now has a side effect of its own, causin ... Show More
1h 35m